GED Capital makes a gross return of 4.0x invested capital and 38% IRR on Vitro Group's exit from GED Fund V

by GED

GED Capital divested Vitro Group through a dual exit route, first selling its flow cytometry division (“Cytognos”) to the healthcare multinational Becton Dickinson in January 2022 and then its mol...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

tuTECHÔ se convierte en la primera empr...

by EY - Ernst & Young

tuTECHÔ, empresa social que lucha contra el sinhogarismo en España, ...

Photos Stream